
EMS-CHEMIE HOLDING Investor Relations Material
Latest events

Q2 2025
11 Jul, 2025

Q1 2025
28 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EMS-CHEMIE HOLDING AG
Access all reports
EMS-CHEMIE HOLDING AG, based in Switzerland, is a prominent manufacturer and supplier of high-performance polymers and specialty chemicals. The company's operations are structured into two primary segments: High Performance Polymers and Specialty Chemicals. The High Performance Polymers segment is notable for its EMS-GRIVORY division, which specializes in the production of high-performance polyamides, offering a wide range of polyamide materials. EMS-EFTEC, another division within this segment, focuses on the supply of adhesives, sealants, and coatings, including application engineering systems, catering to the global automotive industry. The Specialty Chemicals segment encompasses EMS-PATVAG, known for its expertise in airbag igniters, and EMS-GRILTECH, which produces and markets fibers, adhesives, and various chemical products including Grilon, Nexylon, and Nexylene fibers, Griltex hotmelt adhesives, Grilbond adhesion promoters, Primid crosslinkers for powder-coatings, and Grilonit reactive diluents. EMS-CHEMIE HOLDING AG serves a diverse range of industries, including automotive, electro and electronics, industry and consumer goods, optics, and packaging. The company is headquartered in Herrliberg, Zurich, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
EMSN
Country
🇨🇭 Switzerland